This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Prokarium Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Rocky Marc Cranenburgh: Innovator in Vaccine Development
Introduction
Rocky Marc Cranenburgh is a notable inventor based in London, GB. He has made significant contributions to the field of vaccine development, particularly through his innovative work on modified strains of bacteria.
Latest Patents
Cranenburgh holds a patent for a modified strain of Typhi. The present invention relates to the modification of a live attenuated strain of serovar, wherein its natural surface-exposed polysaccharide and flagellin antigens may be converted to, or augmented by, those from other strains of serovars. This invention is particularly relevant for developing components of a vaccine for enteric fever.
Career Highlights
Cranenburgh is associated with Prokarium Limited, a company focused on advancing vaccine technologies. His work has been instrumental in enhancing the efficacy of vaccines, which is crucial for public health.
Collaborations
Cranenburgh collaborates with Annelise Juliette Soulier, contributing to the innovative research and development efforts at Prokarium Limited.
Conclusion
Rocky Marc Cranenburgh's contributions to vaccine development through his patented innovations highlight his role as a key figure in the field. His work continues to pave the way for advancements in public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile